Mutations in ampD cause hyperproduction of AmpC and CmcB β-lactamases and high resistance to β-lactam antibiotics in Chromobacterium violaceum
Microbiology Spectrum · 2025
DOI: 10.1128/spectrum.00916-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2025. Verfasst von Luís Gustavo Laranjeiro und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão P…. Hauptthemen laut MEDLINE: Chromobacterium, beta-Lactamases, Anti-Bacterial Agents, Bacterial Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo, Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo, Fundação para a Ciência e a Tecnologia.
Abstract (Originalsprache)
Bacterial resistance to β-lactam antibiotics mediated by β-lactamase enzymes is widespread worldwide. Chromobacterium violaceum , an environmental Gram-negative bacterial pathogen, is intrinsically resistant to some β-lactam antibiotics. In this work, we found that mutations in an ampD gene, encoding a peptidoglycan-recycling amidase, cause hyperproduction of two chromosomal β-lactamases (AmpC and CmcB), conferring high β-lactam resistance in C. violaceum . Susceptibility tests using Δ ampC , Δ cmcB , and Δ cmcBΔampC mutant strains revealed specific susceptibility profiles to penicillin, cephalosporin, and carbapenem β-lactams, suggesting that AmpC is a broad-spectrum β-lactamase (penicillinase and cephalosporinase), while CmcB is a narrow-spectrum metallo-carbapenemase. β-galactosidase assays indicate that the expression of ampC and cmcB increased in response to β-lactams. We isolated C. violaceum spontaneous mutants resistant to the antibiotic ceftazidime and found that most mutants were also resistant to several other β-lactams and overexpressed ampC and cmcB . DNA sequencing of the three paralog genes encoding the C. violaceum AmpD amidases revealed mutations of different types in AmpD1 (CV_0566) in most of the spontaneous mutants, but no mutation was found in AmpD2 or AmpD3. Analysis of single and combined null amidase mutants revealed overexpression of both β-lactamases and increased resistance to β-lactams only in mutants with deleted ampD1 . When introduced into ampD1 null or spontaneous mutants, the ampD1 gene rescued the antibiotic-related phenotypes. The AmpD1 amidase from C. violaceum has a unique architecture with an N-terminal acetyltransferase domain. Our work offers new insights into the mechanisms of β-lactamase-mediated antibiotic resistance and opens perspectives to improve the treatment of C. violaceum infections. IMPORTANCE Resistance to β-lactam antibiotics reduces the options for treating bacterial infections, posing a threat to public health. In this work, we demonstrated that the intrinsic resistance to β-lactam antibiotics in the environmental pathogen Chromobacterium violaceum is mediated by two chromosomally encoded β-lactamases, AmpC and CmcB, and revealed the mechanism that contributes to their simultaneous expression. Our data indicate that mutations in the peptidoglycan recycling amidase ampD1 , but not in its paralogs ampD2 and ampD3 , lead to stable overexpression of both β-lactamases and increased resistance to β-lactam antibiotics. Remarkably, AmpD1 possesses a unique N-terminal acetyltransferase domain, suggesting a distinct functional mechanism for this enzyme. Our work offers an explanation for the limited effectiveness of many β-lactams in treating C. violaceum infections. Understanding the mechanism of antimicrobial resistance is crucial for developing effective treatments and mitigating the spread of β-lactam-resistant bacteria.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Biologia Celular e Molecular e Bioagentes Patogênicos, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil.
- Departamento de Ciências da Vida, Centro de Ecologia Funcional, Laboratório Associado TERRA, Faculdade de Ciências e Tecnologia, Universidade de Coimbra, Coimbra, Coimbra District, Portugal.
ORCID-Profile: Luís Gustavo Laranjeiro, José F da Silva Neto
Förderung
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Fundação de Apoio ao Ensino, Pesquisa e Assistência do Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto da Universidade de São Paulo
- Fundação para a Ciência e a Tecnologia
Zitieren
APA
Laranjeiro, L. G., Neme, C. E. M., Previato-Mello, M., Batista, B. B., Henriques, I., & da Silva Neto, J. F. (2025). Mutations in ampD cause hyperproduction of AmpC and CmcB β-lactamases and high resistance to β-lactam antibiotics in Chromobacterium violaceum. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00916-25
Vancouver
Laranjeiro LG, Neme CEM, Previato-Mello M, Batista BB, Henriques I, da Silva Neto JF. Mutations in ampD cause hyperproduction of AmpC and CmcB β-lactamases and high resistance to β-lactam antibiotics in Chromobacterium violaceum. Microbiology Spectrum. 2025. doi:10.1128/spectrum.00916-25
BibTeX
@article{Laranjeiro2025,
author = {Laranjeiro, Luís Gustavo and Neme, Carlos Eduardo M and Previato-Mello, Maristela and Batista, Bianca B and Henriques, Isabel and da Silva Neto, José F},
title = {Mutations in ampD cause hyperproduction of AmpC and CmcB β-lactamases and high resistance to β-lactam antibiotics in Chromobacterium violaceum},
journal = {Microbiology Spectrum},
year = {2025},
doi = {10.1128/spectrum.00916-25}
}
EUVIMED